LinkGevity Announces Investment from the KQ Labs Programme Delivered by the Francis Crick Institute
LONDON, Jan. 22, 2025 (GLOBE NEWSWIRE) — LinkGevity, an AI-driven drug discovery company focused on age-related diseases and longevity, today announces it has been selected for the prestigious KQ Labs Programme, delivered by the Francis Crick Institute, Europe's largest biomedical research centre. The KQ Labs Programme provides participants with an equity investment, and access to […]